Deuterated S-lenalidomide

N/A

Report date: 2025/02/28 11:25:37
NME

Base Information

Drug NameDeuterated S-lenalidomide
Drug Alias NameDeuterated1 S-lenalidomideDeuterated1-S-lenalidomideD1-S-lenalidomideDP-053CTP-221
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Deuterated drugs
Mechanisms of ActionCereblon modulators
TargetsCereblon
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDeuterx
China Registration ClassN/A

Develop Information

Active CompaniesDeuterx
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A